CVE-2026-26708

CVE-2026-26708 is a critical-severity vulnerability in Oretnom23 Pharmacy Point Of Sale System with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-89.

Key facts

Description

sourcecodester Pharmacy Point of Sale System v1.0 is vulnerable to SQL Injection in /pharmacy/manage_user.php.

Frequently asked questions

What is CVE-2026-26708?
sourcecodester Pharmacy Point of Sale System v1.0 is vulnerable to SQL Injection in /pharmacy/manage_user.php.
How severe is CVE-2026-26708?
CVE-2026-26708 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2026-26708 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (24th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-26708?
CVE-2026-26708 affects Oretnom23 Pharmacy Point Of Sale System. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-26708?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
Does CVE-2026-26708 have an EU (EUVD) identifier?
Yes. CVE-2026-26708 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-9205.
When was CVE-2026-26708 published?
CVE-2026-26708 was published on 2026-03-02 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Oretnom23 Pharmacy Point Of Sale System

All CVEs affecting Oretnom23 Pharmacy Point Of Sale System →

Other CWE-89 (SQL Injection) vulnerabilities

Browse all CWE-89 (SQL Injection) vulnerabilities →